CNS-localized myeloid cells capture living invading T cells during neuroinflammation.
Animals
CX3C Chemokine Receptor 1
/ metabolism
Cell Communication
Cell Death
Cell Survival
Central Nervous System
/ pathology
Encephalomyelitis, Autoimmune, Experimental
/ immunology
Glucosamine
/ metabolism
Inflammation
/ immunology
Lectins, C-Type
/ metabolism
Lymphocyte Activation
/ immunology
Mannose Receptor
Mannose-Binding Lectins
/ metabolism
Mice
Myeloid Cells
/ pathology
Phagocytosis
Phosphatidylserines
/ metabolism
Receptors, Cell Surface
/ metabolism
Severity of Illness Index
T-Lymphocytes
/ immunology
Th17 Cells
/ immunology
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
01 06 2020
01 06 2020
Historique:
received:
06
05
2019
revised:
20
09
2019
accepted:
17
01
2020
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
17
2
2021
Statut:
ppublish
Résumé
To study the role of myeloid cells in the central nervous system (CNS) in the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), we used intravital microscopy, assessing local cellular interactions in vivo in EAE animals and ex vivo in organotypic hippocampal slice cultures. We discovered that myeloid cells actively engulf invading living Th17 lymphocytes, a process mediated by expression of activation-dependent lectin and its T cell-binding partner, N-acetyl-D-glucosamine (GlcNAc). Stable engulfment resulted in the death of the engulfed cells, and, remarkably, enhancement of GlcNAc exposure on T cells in the CNS ameliorated clinical EAE symptoms. These findings demonstrate the ability of myeloid cells to directly react to pathogenic T cell infiltration by engulfing living T cells. Amelioration of EAE via GlcNAc treatment suggests a novel first-defense pathway of myeloid cells as an initial response to CNS invasion and demonstrates that T cell engulfment by myeloid cells can be therapeutically exploited in vivo.
Identifiants
pubmed: 32219436
pii: 151587
doi: 10.1084/jem.20190812
pmc: PMC7971133
pii:
doi:
Substances chimiques
CX3C Chemokine Receptor 1
0
Cx3cr1 protein, mouse
0
Lectins, C-Type
0
Mannose Receptor
0
Mannose-Binding Lectins
0
Phosphatidylserines
0
Receptors, Cell Surface
0
Glucosamine
N08U5BOQ1K
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2020 Wasser et al.
Déclaration de conflit d'intérêts
Disclosures: The authors declare no competing interests exist.
Références
Trends Immunol. 2005 Feb;26(2):104-10
pubmed: 15668126
Neuron. 2005 May 5;46(3):421-32
pubmed: 15882642
J Biol Chem. 1992 Jan 25;267(3):1719-26
pubmed: 1730714
Prog Neurobiol. 2015 Aug;131:65-86
pubmed: 26067058
Acta Neuropathol. 2004 Sep;108(3):201-6
pubmed: 15235800
Nat Neurosci. 2018 Apr;21(4):541-551
pubmed: 29507414
Anat Rec (Hoboken). 2012 Mar;295(3):372-7
pubmed: 22271432
Mol Immunol. 2015 Aug;66(2):439-50
pubmed: 26010409
Immunity. 2010 Sep 24;33(3):424-36
pubmed: 20870176
Annu Rev Immunol. 2008;26:585-626
pubmed: 18173372
J Exp Med. 2003 May 5;197(9):1073-81
pubmed: 12732654
Ann Neurol. 2018 Jan;83(1):131-141
pubmed: 29283442
Nat Rev Neurosci. 2014 Apr;15(4):209-16
pubmed: 24646669
Biophys J. 2010 Feb 17;98(4):715-23
pubmed: 20159168
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Cold Spring Harb Perspect Biol. 2015 Jul 17;7(10):a020545
pubmed: 26187728
Nat Rev Immunol. 2009 Jun;9(6):393-407
pubmed: 19444307
J Neurosci. 2007 Oct 3;27(40):10714-21
pubmed: 17913905
Nat Rev Immunol. 2015 Sep 15;15(9):545-58
pubmed: 26250739
Br J Exp Pathol. 1968 Aug;49(4):356-9
pubmed: 5692115
Nat Med. 2018 Dec;24(12):1837-1844
pubmed: 30420755
Brain. 2009 May;132(Pt 5):1247-58
pubmed: 19179377
J Neurochem. 2016 Mar;136(5):971-80
pubmed: 26662167
Glia. 2012 Feb;60(2):306-21
pubmed: 22072381
Eur J Immunol. 2007 Jan;37(1):43-53
pubmed: 17171761
J Biol Chem. 2011 Nov 18;286(46):40133-41
pubmed: 21965673
Front Cell Neurosci. 2013 Jan 30;7:6
pubmed: 23386811
Nat Med. 2005 Feb;11(2):146-52
pubmed: 15665833
Cell Mol Life Sci. 2016 Jun;73(11-12):2379-86
pubmed: 27048820
Immunity. 2003 Jul;19(1):71-82
pubmed: 12871640
Nat Rev Mol Cell Biol. 2008 Oct;9(10):796-809
pubmed: 18784728
BMC Biotechnol. 2002 Jun 11;2:11
pubmed: 12079497
Immunology. 1985 Oct;56(2):351-8
pubmed: 3876985
Ann Neurol. 2003 Mar;53(3):292-304
pubmed: 12601697
Exp Neurol. 2010 Sep;225(1):24-8
pubmed: 19409897
Nat Rev Immunol. 2014 Jul;14(7):463-77
pubmed: 24962261
Neurosci Lett. 1999 Aug 6;270(3):153-6
pubmed: 10462117
Lab Invest. 1992 Jul;67(1):88-99
pubmed: 1625450
J Immunol. 2005 Aug 1;175(3):1785-94
pubmed: 16034120
Cytometry. 1987 Sep;8(5):518-25
pubmed: 3665675
Nat Cell Biol. 2011 Jul 31;13(9):1076-83
pubmed: 21804544
J Neurosci Methods. 2015 Jul 15;249:8-15
pubmed: 25864804
Br Med Bull. 1997;53(3):491-508
pubmed: 9374033
J Exp Med. 2015 Apr 6;212(4):481-95
pubmed: 25779633
Trends Immunol. 2015 Oct;36(10):614-624
pubmed: 26431939
Acta Neuropathol. 2015 Feb;129(2):279-95
pubmed: 25500713
Nat Neurosci. 2013 Nov;16(11):1618-26
pubmed: 24077561
EMBO J. 2016 Jan 4;35(1):89-101
pubmed: 26612827
Mol Cell Biol. 2000 Jun;20(11):4106-14
pubmed: 10805752
Immunol Lett. 2014 Jul;160(1):17-22
pubmed: 24698730
J Neuroimmune Pharmacol. 2016 Dec;11(4):721-732
pubmed: 27423192
Glia. 2017 Sep;65(9):1439-1451
pubmed: 28617991